Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hsiang-Wen Lin

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Clinical Therapeutics|December 13, 2006
Trends in off-label beta-blocker use: a secondary data analysisHsiang-Wen Lin, Kathy Phan, Swu-Jane Lin
Journal of Neurology|February 27, 2023
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysisOkti Ratna Mafruhah, Yen-Ming Huang, Hsiang-Wen Lin
Pharmacoeconomics|May 10, 2007
Health utilities using the EQ-5D in studies of cancerA Simon Pickard, Caitlyn T Wilke, Hsiang-Wen Lin, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|February 16, 2018
EQ-5D-Y for the assessment of health-related quality of life among Taiwanese youth with mild-to-moderate chronic kidney diseaseChien-Ning Hsu, Hsiang-Wen Lin, A Simon Pickard, et al.
Health and Quality of Life Outcomes|October 27, 2023
Comparisons of EQ-5D-Y and PedsQL in pediatric patients with mild-to-moderate chronic kidney disease in longitudinal analysesChien-Ning Hsu, You-Lin Tain, Pei-Chen Lu, et al.
Nephrology (Carlton, Vic.)|August 14, 2012
Occurrence of infection among children with nephrotic syndrome during hospitalizationsChang-Ching Wei, I-Wen Yu, Hsiang-Wen Lin, et al.
American Journal of Pharmaceutical Education|August 14, 2008
Conceptual development of a measure to assess pharmacists' knowledge of herbal and dietary supplementsHsiang-Wen Lin, A Simon Pickard, Gail B Mahady, et al.
Clinical Therapeutics|April 5, 2016
Using Patient-reported Outcomes to Compare Relative Burden of Cancer: EQ-5D and Functional Assessment of Cancer Therapy-General in Eleven Types of CancerA Simon Pickard, Ruixuan Jiang, Hsiang-Wen Lin, et al.
European Journal of Clinical Pharmacology|August 10, 2012
Concurrent use of antiplatelets, anticoagulants, or digoxin with Chinese medications: a population-based cohort studyHsin-Hui Tsai, Hsiang-Wen Lin, Chun-Ru Chien, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 23, 2022
Censoring in the time trade-off valuation of worse-than-dead EQ-5D-5L health states: can a time-based willingness-to-accept question be the solution?Meixia Liao, Kim Rand, Zhihao Yang, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Clinical Therapeutics|December 13, 2006
Trends in off-label beta-blocker use: a secondary data analysisHsiang-Wen Lin, Kathy Phan, Swu-Jane Lin
Journal of Neurology|February 27, 2023
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysisOkti Ratna Mafruhah, Yen-Ming Huang, Hsiang-Wen Lin
Pharmacoeconomics|May 10, 2007
Health utilities using the EQ-5D in studies of cancerA Simon Pickard, Caitlyn T Wilke, Hsiang-Wen Lin, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|February 16, 2018
EQ-5D-Y for the assessment of health-related quality of life among Taiwanese youth with mild-to-moderate chronic kidney diseaseChien-Ning Hsu, Hsiang-Wen Lin, A Simon Pickard, et al.
Health and Quality of Life Outcomes|October 27, 2023
Comparisons of EQ-5D-Y and PedsQL in pediatric patients with mild-to-moderate chronic kidney disease in longitudinal analysesChien-Ning Hsu, You-Lin Tain, Pei-Chen Lu, et al.
Nephrology (Carlton, Vic.)|August 14, 2012
Occurrence of infection among children with nephrotic syndrome during hospitalizationsChang-Ching Wei, I-Wen Yu, Hsiang-Wen Lin, et al.
American Journal of Pharmaceutical Education|August 14, 2008
Conceptual development of a measure to assess pharmacists' knowledge of herbal and dietary supplementsHsiang-Wen Lin, A Simon Pickard, Gail B Mahady, et al.
Clinical Therapeutics|April 5, 2016
Using Patient-reported Outcomes to Compare Relative Burden of Cancer: EQ-5D and Functional Assessment of Cancer Therapy-General in Eleven Types of CancerA Simon Pickard, Ruixuan Jiang, Hsiang-Wen Lin, et al.
European Journal of Clinical Pharmacology|August 10, 2012
Concurrent use of antiplatelets, anticoagulants, or digoxin with Chinese medications: a population-based cohort studyHsin-Hui Tsai, Hsiang-Wen Lin, Chun-Ru Chien, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 23, 2022
Censoring in the time trade-off valuation of worse-than-dead EQ-5D-5L health states: can a time-based willingness-to-accept question be the solution?Meixia Liao, Kim Rand, Zhihao Yang, et al.
Pageof 5